메뉴 건너뛰기




Volumn 36, Issue 6, 2015, Pages 342-346

The year in cardiology 2014: Acute coronary syndromes

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; CARDIAC PATIENT; CARDIOLOGY; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BLOOD FLOW; EARLY DIAGNOSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMMUNOTHERAPY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; SLEEP DISORDERED BREATHING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TAKOTSUBO CARDIOMYOPATHY; UNSTABLE ANGINA PECTORIS; UPREGULATION; ADOLESCENT; ADULT; AGED; METABOLISM; MIDDLE AGED; PROCEDURES; RISK ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928229883     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu488     Document Type: Note
Times cited : (3)

References (29)
  • 6
    • 84905859597 scopus 로고    scopus 로고
    • Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: Propensity-matched analysis from the acute catheterization and urgent intervention triage strategy trial
    • Planer D, Mehran R, Ohman EM, White HD, Newman JD, Xu K, Stone GW. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the acute catheterization and urgent intervention triage strategy trial. Circ Cardiovasc Interv 2014;7:285-293.
    • (2014) Circ Cardiovasc Interv , vol.7 , pp. 285-293
    • Planer, D.1    Mehran, R.2    Ohman, E.M.3    White, H.D.4    Newman, J.D.5    Xu, K.6    Stone, G.W.7
  • 8
    • 84893054508 scopus 로고    scopus 로고
    • PLATOstudy group. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: A substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial
    • Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, MahaffeyKW, Steg PG, StoreyRF, James SK. PLATOstudy group. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 2014;129:293-303.
    • (2014) Circulation , vol.129 , pp. 293-303
    • Wallentin, L.1    Lindholm, D.2    Siegbahn, A.3    Wernroth, L.4    Becker, R.C.5    Cannon, C.P.6    Cornel, J.H.7    Himmelmann, A.8    Giannitsis, E.9    Harrington, R.A.10    Held, C.11    Husted, S.12    Katus, H.A.13    Mahaffey, K.W.14    Steg, P.G.15    Storey, R.F.16    James, S.K.17
  • 10
    • 84898962162 scopus 로고    scopus 로고
    • Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: Analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis in Myocardial Infarction 36)
    • O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol 2014;63:1644-1653.
    • (2014) J Am Coll Cardiol , vol.63 , pp. 1644-1653
    • O'malley, R.G.1    Bonaca, M.P.2    Scirica, B.M.3    Murphy, S.A.4    Jarolim, P.5    Sabatine, M.S.6    Braunwald, E.7    Morrow, D.A.8
  • 18
    • 84906261210 scopus 로고    scopus 로고
    • Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: A pre-specified analysis from the EUROMAX trial
    • Zeymer U, van't Hof A, Adgey J, Nibbe L, Clemmensen P, Cavallini C, Ten Berg J, Coste P, Huber K, Deliargyris EN, Day J, Bernstein D, Goldstein P, Hamm C, Steg PG. Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial. Eur Heart J 2014;35:2460-2467.
    • (2014) Eur Heart J , vol.35 , pp. 2460-2467
    • Zeymer, U.1    Van't Hof, A.2    Adgey, J.3    Nibbe, L.4    Clemmensen, P.5    Cavallini, C.6    Ten Berg, J.7    Coste, P.8    Huber, K.9    Deliargyris, E.N.10    Day, J.11    Bernstein, D.12    Goldstein, P.13    Hamm, C.14    Steg, P.G.15
  • 20
    • 84902587640 scopus 로고    scopus 로고
    • The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: A cohort study of the Myocardial Ischaemia National Audit Project (MINAP)
    • Zaman MJ, Stirling S, Shepstone L, Ryding A, Flather M, Bachmann M, Myint PK. The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP). Eur Heart J 2014;35:1551-1558.
    • (2014) Eur Heart J , vol.35 , pp. 1551-1558
    • Zaman, M.J.1    Stirling, S.2    Shepstone, L.3    Ryding, A.4    Flather, M.5    Bachmann, M.6    Myint, P.K.7
  • 23
    • 84928249086 scopus 로고    scopus 로고
    • IMPROVE-IT Trial: A comparison of ezetimibe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes after acute coronary syndromes
    • Chicago, 7 November
    • Cannon CP et al. IMPROVE-IT Trial: a comparison of ezetimibe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes after acute coronary syndromes, presented at the AHA annual scientific sessions, Chicago, 7 November 2014.
    • (2014) Presented at the AHA Annual Scientific Sessions
    • Cannon, C.P.1
  • 27
    • 84890962511 scopus 로고    scopus 로고
    • Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease
    • Nidorf SM, Eikelboom JW, Thompson PL. Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease. J Cardiovasc Pharmacol Ther 2014;19:45-52.
    • (2014) J Cardiovasc Pharmacol Ther , vol.19 , pp. 45-52
    • Nidorf, S.M.1    Eikelboom, J.W.2    Thompson, P.L.3
  • 29
    • 84901943236 scopus 로고    scopus 로고
    • ACC/AHA 2013 methodology for developing clinical data standards: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards
    • Hendel RC, Bozkurt B, Fonarow GC, Jacobs JP, Lichtman JH, Smith EE, Tcheng JE, Wang TY, Weintraub WS. ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circulation 2014;129: 2346-2357.
    • (2014) Circulation , vol.129 , pp. 2346-2357
    • Hendel, R.C.1    Bozkurt, B.2    Fonarow, G.C.3    Jacobs, J.P.4    Lichtman, J.H.5    Smith, E.E.6    Tcheng, J.E.7    Wang, T.Y.8    Weintraub, W.S.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.